Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease
暂无分享,去创建一个
Julia Manasson | Jose U Scher | S. Abramson | E. Pamer | C. Ubeda | A. Neimann | D. Littman | S. Reddy | J. Scher | M. Attur | A. Artacho | J. Manasson | Eric G Pamer | S. Marmon | Dan R Littman | Steven B Abramson | Shoshana Marmon | Mukundan Attur | Alejandro Artacho | Carles Ubeda | Sandrine Isaac | Soumya M Reddy | Andrea Neimann | Samuel Brusca | Tejas Patel | S. Brusca | Sandrine Isaac | T. Patel | Samuel B. Brusca
[1] W. Garrett,et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.
[2] Dafna Gladman,et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.
[3] M. De Vos,et al. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model , 2012, Annals of the rheumatic diseases.
[4] Michael A McGuckin,et al. Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.
[5] T. Mcclanahan,et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.
[6] A. Rizzo,et al. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. , 2012, Arthritis and rheumatism.
[7] B. Vainer,et al. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-α in ulcerative colitis , 1999, American Journal of Gastroenterology.
[8] A. Viale,et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. , 2012, Arthritis and rheumatism.
[9] Vinod Chandran,et al. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. , 2010, Rheumatology.
[10] W. M. Vos,et al. Intestinal Integrity and Akkermansia muciniphila, a Mucin-Degrading Member of the Intestinal Microbiota Present in Infants, Adults, and the Elderly , 2007, Applied and Environmental Microbiology.
[11] H. Vogel,et al. Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR γ to Suppress Colitis , 2012, PloS one.
[12] D. Jewell,et al. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history , 1998, Gut.
[13] P. Rutgeerts,et al. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD , 2014, Gut.
[14] C. Huttenhower,et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis , 2013, eLife.
[15] Xiaoxia Zhu,et al. Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions , 2012, PloS one.
[16] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[17] J. Reveille,et al. Genetics of spondyloarthritis—beyond the MHC , 2012, Nature Reviews Rheumatology.
[18] F. D'armiento,et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. , 2000, The Journal of rheumatology.
[19] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[20] R. Bloomfeld,et al. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease. , 2012, Clinical nutrition.
[21] Marco Scutari,et al. Learning Bayesian Networks with the bnlearn R Package , 2009, 0908.3817.
[22] M. Brown,et al. β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. , 2012, Arthritis and rheumatism.
[23] Leandro Martínez,et al. Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists , 2012, PloS one.
[24] H. Tilg,et al. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss , 2005, Gut.
[25] S. Bull,et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis , 2011, Annals of the rheumatic diseases.
[26] E. Schwarz,et al. RANKL induces heterogeneous DC‐STAMPlo and DC‐STAMPhi osteoclast precursors of which the DC‐STAMPlo precursors are the master fusogens , 2009, Journal of cellular physiology.
[27] P. Vandamme,et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.
[28] M. De Vos,et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. , 1995, The Journal of rheumatology.
[29] H. Kiyono,et al. RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium1 , 2009, The Journal of Immunology.
[30] F. Guarner,et al. Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission , 2013, Inflammatory bowel diseases.
[31] J. Doré,et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. , 2002, Rheumatology.
[32] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[33] F. Toberer,et al. Tissue microarray analysis of RANKL in cutaneous lupus erythematosus and psoriasis , 2011, Experimental dermatology.
[34] Richard A. Flavell,et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.
[35] James A. Foster,et al. Phylogenetics Clearcut : a fast implementation of relaxed neighbor joining , 2006 .
[36] A. Qureshi,et al. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women , 2012, Annals of the rheumatic diseases.
[37] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[38] D. Elewaut,et al. Mucosal Inflammation in Spondylarthritides: Past, Present, and Future , 2011, Current rheumatology reports.
[39] D. Cua,et al. Autoimmunity's collateral damage: Gut microbiota strikes 'back' , 2011, Nature Medicine.
[40] R. Winchester,et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. , 2012, Arthritis and rheumatism.
[41] T. R. Licht,et al. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls. , 2012, Beneficial microbes.
[42] E. Schwarz,et al. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. , 2003, The Journal of clinical investigation.
[43] Ben Lacy Costello,et al. The FASEB Journal • Research Communication Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease , 2022 .
[44] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[45] R. Hammer,et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.